OtherIUPHAR Nomenclature Report
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Richard D. Ye, François Boulay, Ji Ming Wang, Claes Dahlgren, Craig Gerard, Marc Parmentier, Charles N. Serhan and Philip M. Murphy
Pharmacological Reviews June 2009, 61 (2) 119-161; DOI: https://doi.org/10.1124/pr.109.001578
Richard D. Ye
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (R.D.Y); Commissariat à l'Energie Atomique, Institut de Recherches en Technologies et Sciences pour le Vivant, Laboratoire de Biochimie et de Biophysique des Systèmses Intégrés, Grenoble, France (F.B.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5092, Grenoble, France (F.B.); Université Joseph Fourier, Grenoble, France (F.B.); Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland (J.M.W.); Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (C.D.); Department of Pediatrics, Harvard Medical School and Children's Hospital, Boston, Massachusetts (C.G.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (M.P.); Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (C.N.S); and Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (P.M.M.)
François Boulay
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (R.D.Y); Commissariat à l'Energie Atomique, Institut de Recherches en Technologies et Sciences pour le Vivant, Laboratoire de Biochimie et de Biophysique des Systèmses Intégrés, Grenoble, France (F.B.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5092, Grenoble, France (F.B.); Université Joseph Fourier, Grenoble, France (F.B.); Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland (J.M.W.); Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (C.D.); Department of Pediatrics, Harvard Medical School and Children's Hospital, Boston, Massachusetts (C.G.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (M.P.); Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (C.N.S); and Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (P.M.M.)
Ji Ming Wang
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (R.D.Y); Commissariat à l'Energie Atomique, Institut de Recherches en Technologies et Sciences pour le Vivant, Laboratoire de Biochimie et de Biophysique des Systèmses Intégrés, Grenoble, France (F.B.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5092, Grenoble, France (F.B.); Université Joseph Fourier, Grenoble, France (F.B.); Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland (J.M.W.); Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (C.D.); Department of Pediatrics, Harvard Medical School and Children's Hospital, Boston, Massachusetts (C.G.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (M.P.); Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (C.N.S); and Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (P.M.M.)
Claes Dahlgren
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (R.D.Y); Commissariat à l'Energie Atomique, Institut de Recherches en Technologies et Sciences pour le Vivant, Laboratoire de Biochimie et de Biophysique des Systèmses Intégrés, Grenoble, France (F.B.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5092, Grenoble, France (F.B.); Université Joseph Fourier, Grenoble, France (F.B.); Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland (J.M.W.); Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (C.D.); Department of Pediatrics, Harvard Medical School and Children's Hospital, Boston, Massachusetts (C.G.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (M.P.); Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (C.N.S); and Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (P.M.M.)
Craig Gerard
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (R.D.Y); Commissariat à l'Energie Atomique, Institut de Recherches en Technologies et Sciences pour le Vivant, Laboratoire de Biochimie et de Biophysique des Systèmses Intégrés, Grenoble, France (F.B.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5092, Grenoble, France (F.B.); Université Joseph Fourier, Grenoble, France (F.B.); Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland (J.M.W.); Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (C.D.); Department of Pediatrics, Harvard Medical School and Children's Hospital, Boston, Massachusetts (C.G.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (M.P.); Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (C.N.S); and Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (P.M.M.)
Marc Parmentier
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (R.D.Y); Commissariat à l'Energie Atomique, Institut de Recherches en Technologies et Sciences pour le Vivant, Laboratoire de Biochimie et de Biophysique des Systèmses Intégrés, Grenoble, France (F.B.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5092, Grenoble, France (F.B.); Université Joseph Fourier, Grenoble, France (F.B.); Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland (J.M.W.); Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (C.D.); Department of Pediatrics, Harvard Medical School and Children's Hospital, Boston, Massachusetts (C.G.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (M.P.); Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (C.N.S); and Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (P.M.M.)
Charles N. Serhan
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (R.D.Y); Commissariat à l'Energie Atomique, Institut de Recherches en Technologies et Sciences pour le Vivant, Laboratoire de Biochimie et de Biophysique des Systèmses Intégrés, Grenoble, France (F.B.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5092, Grenoble, France (F.B.); Université Joseph Fourier, Grenoble, France (F.B.); Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland (J.M.W.); Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (C.D.); Department of Pediatrics, Harvard Medical School and Children's Hospital, Boston, Massachusetts (C.G.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (M.P.); Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (C.N.S); and Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (P.M.M.)
Philip M. Murphy
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois (R.D.Y); Commissariat à l'Energie Atomique, Institut de Recherches en Technologies et Sciences pour le Vivant, Laboratoire de Biochimie et de Biophysique des Systèmses Intégrés, Grenoble, France (F.B.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5092, Grenoble, France (F.B.); Université Joseph Fourier, Grenoble, France (F.B.); Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland (J.M.W.); Department of Rheumatology and Inflammation Research, University of Göteborg, Göteborg, Sweden (C.D.); Department of Pediatrics, Harvard Medical School and Children's Hospital, Boston, Massachusetts (C.G.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Brussels, Belgium (M.P.); Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (C.N.S); and Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (P.M.M.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherIUPHAR Nomenclature Report
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Richard D. Ye, François Boulay, Ji Ming Wang, Claes Dahlgren, Craig Gerard, Marc Parmentier, Charles N. Serhan and Philip M. Murphy
Pharmacological Reviews June 1, 2009, 61 (2) 119-161; DOI: https://doi.org/10.1124/pr.109.001578
OtherIUPHAR Nomenclature Report
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Richard D. Ye, François Boulay, Ji Ming Wang, Claes Dahlgren, Craig Gerard, Marc Parmentier, Charles N. Serhan and Philip M. Murphy
Pharmacological Reviews June 1, 2009, 61 (2) 119-161; DOI: https://doi.org/10.1124/pr.109.001578
Jump to section
- Article
- Abstract
- I. Introduction and Historical Overview
- II. The Expanded Family of Formyl Peptide Receptors
- III. Ligands for the Formyl Peptide Receptor Family of Receptors
- IV. Structure-Function Relationship of the Formyl Peptide Receptor Family of Receptors
- V. Regulation of Formyl Peptide Receptors
- VI. Formyl Peptide Receptor Signal Transduction and Activation of Cell Functions
- VII. A New IUPHAR-Approved Nomenclature for the Formyl Peptide Receptor Family
- VIII. Unmet Challenges and Future Perspetives
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement